BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

CogState Ltd (CGS.AX) Release: Test For Alzheimer's Based On Playing Cards Is Shown At BIO 2004, Highlights Australia Innovation


10/19/2005 5:11:42 PM

SAN FRANCISCO, June 8 /PRNewswire/ -- The Australian biotechnology company, CogState, has developed a computerized test of cognition and brain function based on playing cards. Initially developed for work with the aboriginal community of Australia, the card-based test is considered to be truly cross-cultural.

CogState (http://www.cogstate.com/) recently signed a deal with Pfizer to market tests for Alzheimer's Disease. The company's card-based test also was approved by the Australian Alzheimer's Association as a method to gather baseline data for people over 50, providing a way to detect any early signs of the disease so that intervention can start as soon as possible.

Like a thermometer for the brain, the test is used to test for brain injury in U.S. athletes, including American collegiate amateur boxers (as shown in a study to be discussed this week at the American College of Sports Medicine meeting in Indianapolis, Ind.) and also to determine effects of concussion in sports groups such as the U.S. Olympic Ski Team, the South African Rugby League team and the UK Jockey Club.

More information about the card-based, computerized testing of brain function and demonstrations of the test are available from CogState executives attending BIO 2004 this week.

Further information regarding Victoria, Australia's biotechnology initiatives is available on the web, at http://www.biotechnology.vic.gov.au/.

Government of Victoria, Australia

CONTACT: Dr. Peter Bick, CEO of CogState, 011-61-408-415-823, or+1-415-487-1770; or Tania Ewing, Media Consultant, 011-61-428-378-422, orWendy Lewis of FS Communications, +1-650-691-1488, or cell, +1-408-230-1060,both for Government of Victoria, Australia


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->